Ted’s Brain Science Announces US Patent Issuance of Trans-Resveratrol Topical Medication for Pain
Dallas, Texas, August 12, 2022 — Ted’s Brain Science announced that the US Patent Office granted a patent for a topical medication containing trans-resveratrol. Trans-resveratrol has been shown to be effective in activating AMPK (5′ adenosine monophosphate-activated protein kinase) and thereby reduce pain. The Company, founded by two neuroscientists at University of Texas at Dallas, through pre-clinical research, discovered that resveratrol appears to turn the volume on pain nerves back to normal levels. False pain gets eliminated, but true pain signals can still get through. Dr. Ted Price’s peer-reviewed, pre-clinical neuroscience research has suggested that a molecule found in grape skins and other plants may target pain-sensing nerves in a new way for advanced pain relief. The Company currently markets several products containing trans-resveratrol for pain relief and is developing several new products all directed at pain relief.
For Inquiries, Please Contact:
Ted’s Brain Science, Inc.
2024 W. 15th Street, Suite F. #371
Plano, TX 75075